In the tumor microenvironment, cancer epithelial stem cells utilize the PD-L1 pathway to escape immune system surveillance by suppressing the cytotoxic response following the binding of PD-L1 ligands expressed by cancer stem epithelial cells to the PD-1 receptor on T cells [18,19,20,21]. Here, CD274 is linked to neoplasm.